| |
 |
Branko Stefanovic, Ph.D.
Florida State University
College of Medicine
Dept. of Biomedical Sciences
1115 West Call Street
Tallahassee, FL 32306-4300
Office: (850) 644-7600
Dr. Stefanovic's Faculty Profile |
|
Research Interests |
Liver fibrosis (with its end stage, cirrhosis) is the 8th
leading cause of death in the USA. There is no cure for liver
fibrosis.
Main causes of liver fibrosis are alcohol abuse, infection
with
hepatitis B or C viruses, NASH syndrome, cholestasis of
various etiologies and genetic diseases. 95% of liver cancers
appear in cirrhotic livers. Other major complications of liver
fibrosis include jaundice, varicose bleeding, portal
hypertension and ascites. Liver fibrosis is characterized by
deposition of collagen type I within the space of Disse of the
liver sinusoids. In normal liver type I collagen represents 1%
of total liver proteins, while in cirrhotic liver it can
account for
50% of the total proteins. Type I collagen is synthesized in
the liver by a minor cell population called
hepatic stellate
cells. Major liver cells, hepatocytes, which are responsible
for almost all liver functions, have a great potential to
regenerate. However, in fibrosis liver regeneration is
deficient because type I collagen is not a natural matrix
within which hepatocytes can grow. Patients with liver
fibrosis die because of uncontroled synthesis of type I
collagen by the activated hepatic stellate cells (HSCs).
Therefore, to understand and help find a cure for liver
fibrosis my lab studies activation of hepatic stellate cells,
regulation of expression of genes encoding for type
I.collagen and conection between inflammation and fibrosis. |
|
|
|
Current Projects |
Discovery of novel genes involved in activation of HSCs
Hepatic stellate cells (HSCs, also named Ito cells, lipocytes,
or fat-storing cells) are the major cell type responsible for
collagen synthesis in the cirrhotic liver. In normal liver,
quiescent HSCs store vitamin, but only express trace
amounts of type I collagen. Upon a fibrogenic stimulus,
HSCs become activated, a process in which they lose
retinoid droplets, proliferate, change morphologically into
myofibroblasts, and increase their synthesis of extracellular
matrix proteins. We routinely isolate HSCs from rat livers to
study their activation in vitro. We also use animal models of
liver injury to study HSCs activation in vivo.
Characterization
of genes responsible for activation of HSCs is another major
project in my lab. To discover genes relevant for activation
of HSCs my lab has obtained three DNA microarray data sets
on gene expression profiles in HSCs and cirrhotic livers.
The first DNA microarray compared gene expression in
normal and cirrhotic human livers. This expression profile
allowed us to identify upregulated and down regulated genes
in alcohol or hepatitis induced cirrhosis. The second DNA
microarray compared gene expression between isolated
quiescent HSCs and activated HSCs. These results allowed
us to identify genes which are expressed during activation of
HSCs. The third data set is a comparison of gene expression
between proliferating and senescent HSCs. This allowed us
to identify genes responsible for proliferation of HSCs.
Based on these results we identified hundreds of novel and
relevant genes, which include transcription factors, RNA
binding proteins, cytokines, chemokines and regulators of
signal transduction. The function of these genes will be
analyzed in HCSs and in animal models of liver fibrosis
using techniques for analysis of mRNA and proteins. In
addition, knock-out mice will be obtained for some of these
genes to study their role in the whole organism.
Regulation of expression of type I collagen
Biosynthesis of type I collagen is a complex process, which
requires the coordinated expression of two genes, collagen
α1(I) and collagen α2(I). Polypeptides encoded by
these
genes fold into heterotrimeric protein, type I collagen. The
main step in regulation of expression of these genes is
binding of RNA-binding proteins to collagen mRNAs. These
RNA binding proteins recognize a unique structure called the
5’ stem-loop. Binding of the protein factors increases in
activation of HSCs, which leads to an increased synthesis of
type I collagen. We have discovered this mechanism several
years ago and described its functional significance in several
papers. Cloning and characterization of the regulatory
proteins which bind collagen 5’ stem-loop is one major
project in my lab. To this goal we use RNA-affinity
purification techniques, expression screening of cDNA
libraries and methods for studing RNA-protein interactions.
Recently, we have developed a knock-in mouse in which we
have mutated the 5’ stem-loop in the context of the
endogenous collagen α1(I) gene. This will enable us to
study
the unique aspect of collagen gene regulation in vivo and in
animal models of liver fibrosis. When cloned, the 5’ stemloop
binding proteins will be characterized as a major step
towards developing specific drugs for liver fibrosis, as well
as
fibrosis of other organs.
Inflammation and liver fibrosis
The causative agents of liver fibrosis induce chronic
inflammation and prolonged inflammation usually precedes
fibrosis. The molecular events linking inflammation and
fibrosis are poorly understood. KC is a proinflamatory
chemokine, expression of which is upregulated in patients
with alcoholic cirrhosis and acute alcoholic hepatitis. The
only well studied function of KC is chemotaxis of neutrophils
to the site of tissue injury. We have shown that activated
HSCs express KC, as well as its receptor CXCR2,
suggesting that they can be stimulated in an autocrine
manner. In the whole liver, expression of KC gene is
regulated by KC protein in a positive feedback manner. If
triggered, this positive feedback results in accelerated liver
injury with increased expression of proinflammatory and
profibrotic genes. Thus, expression of KC must be tightly
controlled and its upregulation may be of relevance for
development of liver failure in alcoholic subjects. This
project
is aimed to further elucidate the role of KC in liver
fibrosis.
We constructed a recombinant adenovirus containing the KC
gene, which will allow us to specifically express KC in the
liver. After injection into mice the effects of KC on the
liver
will be examined by histology, by measurment of liver
enzymes and by expression of profibrotic and proinflamatory
genes. Comprehensive changes in gene expression induced
by overexpression of KC will be analyzed by DNA microarray
technology. A preliminary DNA microarray experiment
indicated that overexpression of KC resulted in upregulation
of 1000 genes and downregulation of 800 genes in the
mouse liver. The expression of the highest upregulated gene
was increased 300 fold, while the expression of the most
downregulated gene was decreased 800 fold, suggesting dramatic
changes. By this approach novel genes involved in linking
inflammation and fibrosis will be discovered. They will be
subjected to further study as possible targets for drug
development.
 |
|
|
|
Current Laboratory Members |
Dr. Feng Jiang, postdoc
Lela Stefanovic, lab. tech
Dillon Fritz, grad. student
Mary Cae, grad student |
|
|
|
Selected References |
|
Stefanovic B. New insights into regulation of type I
collagen expression. J. Biol. Sci. 2004. In press. Lela
Stefanovic, Chad E. Stephens, David Boykin, Branko
Stefanovic. Inhibitory effect of dicationic
diphenylfurans on production of type I collagen by human
fibroblasts and activated hepatic stellate cells. 2004. J.
Biol. Sci. In press.
Stefanovic B, Rippe RA. Collagen Gene Regulation in
the Hepatic Stellate Cell. In: Molecular Mechanisms of Liver
Disease. Oxford Press & IBH (India) & M/s Sc Pub (USA). 2004.
Stefanovic B, Stefanovic L, Schnabl B, Bataller R,
Brenner DA. TRAM2 Protein Interacts with Endoplasmic Reticulum
Ca2_ Pump Serca2b and Is Necessary for Collagen Type I
Synthesis. Mol.Cell.Biol., 2004 Feb, p. 1758-1768, Vol. 24,
No. 4.
Rippe RA, Stefanovic B. Techniques to Assess the
Molecular Mechanisms Controlling Gene
Regulation. In: Fibrosis Research: Methods and protocols.
Varga J, Brenner DA, Phan SH (Editors).
2004. The Humana Press Inc, Totowa, NJ.
|
|
|
|